Using pharmacogenomics for oncology to help optimize therapy

The effectiveness and toxicity of several medications commonly prescribed to cancer patients vary with the patient’s genetic makeup. Testing for well-known germline genetic variations can enable more effective treatments and better outcomes. Targeted panels of these variations can be tested with either PCR or sequencing technology. Translational Software®’s cloud-based reporting platform allows laboratories to process the results of these tests and provide reports covering pharmacogenomics for oncology to clinicians that provides actionable guidance toward improving medication decisions.

Complete the contact form to add pharmacogenomics for oncology reporting for your clinicians. Opt-in to receive regular updates from Translational Software®.